Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Business Model:
Revenue: $14.6M
Employees: 501-1,000
Zymergen was acquired by
Ginkgo Bioworks.
The acquisition happend on 2022-07-25.
Details of the transaction were not public
Address: 5980 Horton Street
City: Emeryville
State: CA
Zip: 94608
Country: US
Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Contact Phone:
+14158018073
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/22/2021
IPO Valuation:
$3B
Ticker Symbol:
ZY
IPO Price:
$31/share
Amount Raised:
$500M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
5/2021 | Lodo Therapeutics | |
3/2020 | enEvolv | |
1/2018 | Radiant Genomics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|